Rena Buckstein

Biography

Dr. Buckstein's research is clinical and focused on novel biological therapies for MDS and lymphomas. She is a clinician-investigator and interacts closely with the scientists of Sunnybrook Research Institute and elsewhere on collaborative projects. She conducts investigator-initiated research in the following areas: targeted therapy and immunotherapy, red blood cell transfusions in MDS, MDS mutations as a component of aging, health outcomes research, patient reported outcomes, frailty and comorbidity as prognostic factors. Dr. Buckstein is supported by research funding from the Canadian Institutes of Health Research and Canadian Cancer Society Research Institute.

Research Interest

Novel biologic therapies for hematological malignancies, Myelodysplastic syndromes (MDS), Lymphomas, Impact of patient-related factors on clinical and patient-reported outcomes in MDS, Factors that impact quality of life in MDS.